Acute Porphyria Drugs

Monograph

M01AC06 - Meloxicam
Propably not porphyrinogenic
PNP

Rationale
Substrate for CYP 2C9 and 3A4. One list consider it probably safe.
Chemical description
Tabl, supp, 7-15 mg/d. Analgetic, antipyretic och anti-inflammatory inhibitor of prostaglandin synthesis used in osteoarthrosis. Oxicam derivative, extensively metabolized by hydroxylation by CYP 2C9 (major reaction) and 3A4 (minor reaction). Inhibitor of CYP 2C9. South African list: use with care
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes M01A / M01AC or go back.
References
Tradenames

Meloxicam Meloxicam · Mobic Meloxicam · Melozaltan · Movalis Camelox · Meloxan · Meloxep · Meloxicam · Movalis · Noflamen Meloxicam · Mobic Melox · Meloxicam · Movalis Meloxicam · Mobic Duplicam · Meloxicam Meloxicam Aglan · Aspicam · Aspicam Bio · Difortan · Mel · Melobax · Meloksam · Meloxicam · MeloxiMed Forte · Meloxistad · Moilec · Movalis · Movatec · Opokan · Opokan-forte · Remolexam · Trosicam Meloxicam · Mobic Mobic Lormed · Melobax · Melox · Meloxicam · Meloxistad · Mexolan · Movalis · Noflamen · Normelox · Recoxa · Remolexam Melox · Mexolan · Movalis · Recoxa Lormed · Melox · Meloxicam · Meloxistad · Mexolan · Movalis · Recoxa Meloksikam · Melox · Movalis Celomix · Lormed · Meloksikam · Melokssia · Meloxan · Movalis
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙